Company & Sponsor Intelligence
KU Leuven
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting0
Completed4
Countries1
Therapeutic footprint
alzheimersparkinsonsstroke
Indexed studies
NCT06738290Predicting Motor Learning of an Upper Limb Task Based on Behavioral and Disease-specific Characteristics in Patients With Parkinson's Disease
parkinsons · BelgiumCOMPLETED
parkinsons · BelgiumCOMPLETED
NCT06536322Evaluation of the Use of a Novel Oral Health Screening Instrument by Caregivers in Nursing Homes
alzheimers · BelgiumNA
alzheimers · BelgiumNA
NCT02287207Effects of Transcranial Direct Current Stimulation on Fine Motor Skills in Parkinson's Disease: a Pilot Study
parkinsons · BelgiumNA
parkinsons · BelgiumNA
NCT04185740Medication Responsiveness in Parkinson's Disease
parkinsons · BelgiumPHASE2
parkinsons · BelgiumPHASE2
NCT03458611Virtual Reality Attention Training in Stroke Patients
stroke · BelgiumNA
stroke · BelgiumNA
NCT05970367Intensive Motor Rehabilitation With Technology for Patients With Central Neurological Disease
stroke · BelgiumNA
stroke · BelgiumNA
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →